文献速递消化内镜

丙泊酚与咪达唑仑(±短效阿片类)在结肠镜镇静中的系统评价与荟萃分析

Propofol versus midazolam with or without short-acting opioids for sedation in colonoscopy: a systematic review and meta-analysis of safety, satisfaction, and efficiency outcomes.
PubMed 文献 · Gastrointest Endosc · 2020-01-10

该系统评价纳入9项随机对照试验共1427例结肠镜患者,比较丙泊酚与咪达唑仑(±短效阿片类)的镇静效果。

要点

  • 丙泊酚与咪达唑仑(±短效阿片类)在结肠镜镇静中的心肺不良事件无显著差异。
  • 丙泊酚组恢复时间更短(中位差值3分6秒),操作时间两组相似。

核心结论

  • 丙泊酚与咪达唑仑(±短效阿片类)均可使结肠镜患者获得高满意度且看似安全,丙泊酚的边际获益仅为满意度和恢复时间的轻微改善。

研究设计与样本

  • 系统检索Medline、Embase和Cochrane图书馆(至2018年7月30日)的随机对照试验,纳入9项研究共1427例患者。
  • 心肺结局采用混合效应条件logistic模型合并比值比,满意度和效率结局采用随机效应模型合并标准化均数差(SMD)。

主要发现

  • 两组在低血压、低氧血症、心动过缓等心肺结局方面无显著差异。
  • 两组患者满意度均高,多数患者愿意未来接受相同镇静方案的结肠镜检查。

临床怎么用

  • 结肠镜镇静选择丙泊酚或咪达唑仑(±短效阿片类)均可,两者安全性及患者满意度均高。
  • 若追求更短恢复时间或更高患者满意度,可优先考虑丙泊酚,但需注意其边际获益较小。

局限性

  • 患者满意度合并结果存在较大异质性。
  • 纳入研究数量有限(9项),样本量1427例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Propofol is increasingly being used for sedation in colonoscopy; however, its benefits over midazolam (± short-acting opioids) are not well quantified. The objective of this study was to compare safety, satisfaction, and efficiency outcomes of propofol versus midazolam (± short-acting opioids) in patients undergoing colonoscopy. METHODS: We systematically searched Medline, Embase, and the Cochrane library (to July 30, 2018) for randomized controlled trials of colonoscopies performed with propofol versus midazolam (± short-acting opioids). We pooled odds ratios for cardiorespiratory outcomes using mixed-effects conditional logistic models. We pooled standardized mean differences (SMDs) for patient and endoscopist satisfaction and efficiency outcomes using random-effects models. RESULTS: Nine studies of 1427 patients met the inclusion criteria. There were no significant differences in cardiorespiratory outcomes (hypotension, hypoxia, bradycardia) between sedative groups. Patient satisfaction was high in both groups, with most patients reporting willingness to undergo a future colonoscopy with the same sedative regimen. In the meta-analysis, patients sedated with propofol had greater satisfaction than those sedated with midazolam (± short-acting opioids) (SMD, .54; 95% confidence interval [CI], .30-.79); however, there was considerable heterogeneity. Procedure time was similar between groups (SMD, .15; 95% CI, .04-.27), but recovery time was shorter in the propofol group (SMD, .41; 95% CI, .08-.74). The median difference in recovery time was 3 minutes, 6 seconds shorter in patients sedated with propofol. CONCLUSIONS: Both propofol and midazolam (± short-acting opioids) result in high patient satisfaction and appear to be safe for use in colonoscopy. The marginal benefits to propofol are small improvements in satisfaction and recovery time.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Dossa F, Medeiros B, Keng C, et al. Propofol versus midazolam with or without short-acting opioids for sedation in colonoscopy: a systematic review and meta-analysis of safety, satisfaction, and efficiency outcomes. Gastrointest Endosc. 2020. PMID: 31926966. doi:10.1016/j.gie.2019.12.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。